- Registration date2024-03-28
-
Attached file
Minister for Trade Inkyo Cheong met Mark Smedley, a senior vice president of Thermo Fisher Scientific, on March 28 in Seoul to discuss the global pharma and biotech company’s prospects of investment in establishing a raw and subsidiary biomaterials production facility in Korea.
Trade Minister Cheong remarked that “Samsung, Lotte, Celltrion and other major domestic firms are aggressively expanding investment to bolster productivity in line with Korea’s aim to become a global pharmaceutical manufacturing powerhouse,” and added that “there is a reason why Merck, Sartorius, Cytiva, and other world-leading biomaterials companies have selected Korea as the final investment destination.”
Meanwhile, in addition to bio, the global pharma company revealed plans for cooperation with Korea’s battery and semiconductor firms to seek solutions to battery quality improvement.